# RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy

> **NCT05229029** · PHASE2 · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 196 (estimated)

## Conditions studied

- Cancer-related Problem/Condition

## Interventions

- **DRUG:** TCM Formula
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05229029
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-02
- **Primary completion:** 2023-09-01
- **Final completion:** 2024-06-30
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2024-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05229029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05229029, "RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05229029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*